Primary neuroendocrine tumors of the main pancreatic duct: a rare entity
- 251 Downloads
Very few cases of primary neuroendocrine tumors of the main pancreatic duct have been reported. This paucity has hampered an accurate description of the distinctive clinical and pathological features of these tumors and the correct evaluation of the diagnostic and therapeutic problems which they may raise. We report here five additional cases in order to underline the clinical, histological, and immunohistochemical features of this tumor entity. There were three male and two female, aged 43–72 years; in all patients, but one, who presented with epigastric pain, the diagnosis was made after the incidental discovery of a dilatation of the main pancreatic duct. The preoperative diagnosis was ductal adenocarcinoma in one case, IPMN in one case and neoplastic stenosis of unknown etiology in four cases. Surgical resection was performed in all cases. The diagnosis of neuroendocrine tumor was made at histological examination. All lesions were small, ranging from 5 to 15 mm. They had a predominantly intramural growth. The growth pattern was nodular in three cases, circumferential in two; there was no intra-luminal component. All cases were well-differentiated neuroendocrine neoplasms of low histological grade (G1); four cases expressed serotonin. One case was associated with regional lymph node metastases. All cases were cured by surgery alone; no recurrence was observed at the end of the follow-up period. In conclusion, despite their rarity, primary neuroendocrine tumors of the main pancreatic duct deserve recognition and must be considered in the etiological diagnosis of ductal stenosis.
KeywordsGastroenteropancreatic neuroendocrine tumors Main pancreatic duct Serotonin Carcinoid tumors
Conflict of interest statement
We declare that we have no conflict of interest.
- 11.Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401PubMedCrossRefGoogle Scholar
- 12.Solcia E, Klöppel G, Sobin L (2000) Histological typing of endocrine tumours, 2nd edn. Springer, New YorkGoogle Scholar
- 13.Rindi G, Klimstra DS, Arnold R, Klöppel G, Bosman FT, Komminoth P, Capella C, Solcia E (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. IARC, Lyon, pp 13–14Google Scholar
- 14.Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley, New YorkGoogle Scholar
- 21.Azumi Y, Isaji S, Kato H, Kuriyama N, Kishiwada M, Hamada T, Mizuno S, Usui M, Sakurai H, Tabata M, Inoue H, Katsurahara M, Takei Y, Uchida K, Shiraishi T (2009) A case of a tiny (1.2 cm) non-functioning pancreatic endocrine tumor invading the main pancreatic duct successfully treated by laparoscopy-assisted distal pancreatectomy with splenectomy. Suizo 24:717–725CrossRefGoogle Scholar
- 37.Albores-Saavedra J, Batich K, Hossain S, Henson DE, Schwartz AM (2009) Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the surveillance, epidemiology, and end results program. Ann Diagn Pathol 13:378–383PubMedCrossRefGoogle Scholar